RELEASE: TAF Coalition Files Amicus Brief in Ninth Circuit Island Industries v. Sigma Corp. case
TAF Coalition’s brief addressed the critically important issue of whether customs fraud is actionable under the False Claims Act.
Supreme Court Holds That the Government Must Intervene in Order to Move to Dismiss Over a Relator’s Objection
Ultimately, however, the Court emphasized that the government would likely prevail on its motion to dismiss “in all but the most exceptional cases.”
Supreme Court Rejects Post Hoc “Objective Reasonableness” Standard and Reaffirms Defendants’ Contemporaneous Subjective Beliefs May Determine Scienter in False Claims Act Cases
The SuperValu decision is a resounding victory for the government and whistleblowers.
RELEASE: TAF Applauds Unanimous Supreme Court Decision Upholding False Claims Act
“Today’s unanimous decision is a victory for whistleblowers and holding fraudsters to account," said Jeb White, President of TAF Coalition.
Recent $9.9 Million Visa Fraud Settlement Shows Potential for False Claims Act Cases
These settlements show that whistleblowers can bring qui tam suits under the False Claims Act suits to seek redress for many types of fraud against the government.
Supreme Court Appears Poised to Reverse SuperValu and Safeway Decisions
During the argument today, a majority of the Court appeared inclined to reverse the Seventh Circuit decisions.
Follow the Money: Private Equity Could Co-Opt Supervalu For Greater Profits
Private equity investment in healthcare means that those making decisions do so with a view toward maximizing returns on investment.
Whistleblowers Play Key Role in Exposing Medicare Advantage Fraud
While Medicare Advantage was supposed to be a less expensive alternative to traditional fee-for-service Medicare, it’s turned out to be more expensive.
President Biden’s Budget Proposal Highlights the Importance of Combating Fraud on Government Programs
The False Claims Act will play an important role in achieving the priorities set out in the President’s budget, regardless of whether it is adopted.
The Year Ahead: Federal Regulatory Developments to Watch
In 2023, two important developments will be coming from the Centers for Medicare & Medicaid Services to clarify the reach of the federal False Claims Act.
